Home › Neoplasms by Histologic Type › Tennessee › Nashville
Neoplasms by Histologic Type clinical trials in Nashville, TN
3 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- Vanderbilt University, Ingram Cancer Center, Nashville
Neoplasms by Histologic Type trials in other cities
- Atlanta, GA5 studies
- Boston, MA5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Chicago, IL4 studies
- St. Louis, MO3 studies
- Baldwin Park, CA3 studies
- San Francisco, CA3 studies
- Tampa, FL3 studies
- New York City, NY3 studies
- Dallas, TX3 studies
- Clifton, NJ3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer80 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.